Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., often referred to as Prestige Brands, is a leading player in the consumer healthcare industry, headquartered in Great Britain. Founded in 1999, the company has established a strong presence in North America and other key markets, focusing on over-the-counter healthcare products. Specialising in a diverse range of categories, Prestige Brands offers unique solutions in pain relief, cold and allergy, and personal care. Their portfolio includes well-known brands that resonate with consumers, setting them apart in a competitive landscape. With a commitment to quality and innovation, Prestige Consumer Healthcare has achieved significant milestones, solidifying its market position as a trusted provider of effective healthcare solutions. The company continues to expand its reach, driven by a dedication to enhancing consumer well-being.
DitchCarbon Score
How does Prestige Consumer Healthcare Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Prestige Consumer Healthcare Inc's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Prestige Consumer Healthcare Inc's reported carbon emissions
In 2024, Prestige Consumer Healthcare Inc. reported total carbon emissions of approximately 149,927,270 kg CO2e. This figure includes 1,438,380 kg CO2e from Scope 1 emissions, 7,141,310 kg CO2e from Scope 2 emissions, and a significant 141,347,580 kg CO2e from Scope 3 emissions. This data reflects a comprehensive disclosure of emissions across all relevant scopes. Comparatively, in 2021, the company recorded total emissions of about 107,165,000 kg CO2e, with Scope 1 emissions at 1,304,000 kg CO2e, Scope 2 emissions at 5,530,000 kg CO2e, and Scope 3 emissions at 100,330,000 kg CO2e. This indicates an increase in total emissions over the three-year period, particularly in Scope 3 emissions, which are often the largest contributor in consumer goods sectors. Despite the increase in emissions, Prestige Consumer Healthcare Inc. has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or SBTi commitments. The company’s climate strategy appears to be in the early stages, with no significant pledges or initiatives reported. Overall, while Prestige Consumer Healthcare Inc. has made strides in emissions reporting, the lack of defined reduction targets suggests an opportunity for further commitment to climate action in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 1,304,000 | 0,000,000 |
| Scope 2 | 5,530,000 | 0,000,000 |
| Scope 3 | 100,330,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Prestige Consumer Healthcare Inc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
